12 Results for "

MDA-9

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "MDA-9" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-124813
CAS No.: 2083618-79-3
Purity:  99.29%
Synonyms: 113B7
Target:  

FAK EGFR MMP NF-κB SDCBP

Research Areas:  

Cancer

PDZ1i (113B7) is a inhibitor of MDA-9/Syntenin, with selective binding to the PDZ1 domain. PDZ1i inhibits radiation-induced invasion of glioblastoma (GBM) cells, radiosensitizes GBM cells, and impairs GBM-related signaling pathways (including Src/EphA2, EGFRvIII/FAK, and NF-κB). PDZ1i reduces radiation-induced secretion of invasion-related proteases (MMP-2, MMP-9, ADAM9). PDZ1i shows anti-tumor effects in nude mice bearing intracranial U1242-luc xenografts or GBM xenografts. PDZ1i can be used for the study of glioblastoma (GBM), breast cancer and prostate cancer .
Cat. No.: HY-156247
Target:  

SDCBP NF-κB MMP

Research Areas:  

Cancer

IVMT-Rx-3 is a inhibitor of SDCBP targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin. IVMT-Rx-3 blocks MDA-9/Syntenin interaction with Src, reduces NF-κB activation, and inhibits MMP-2/MMP-9 expression. IVMT-Rx-3 inhibits Melanoma Metastasis [1]
Cat. No.: HY-RS18078
Research Areas:  

Others

Sdcbp Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sdcbp gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-P85470
Synonyms: SDCBP; MDA9; SYCL; Syntenin-1; Melanoma differentiation-associated protein 9; MDA-9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; TACIP18; Scaffold protein Pbp1; Syndecan-binding protein 1

Host:  

Mouse

Application:  

WB

Reactivity:  

Human, Rat, Dog, Pig

Cat. No.: HY-P81310A
Synonyms: SDCBP; MDA9; SYCL; Syntenin-1; Melanoma differentiation-associated protein 9; MDA-9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; TACIP18; Scaffold protein Pbp1; Syndecan-binding protein 1

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, FC

Reactivity:  

Human

Cat. No.: HY-RS12583
Research Areas:  

Others

SDCBP Human Pre-designed siRNA Set A contains three designed siRNAs for SDCBP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-P85539
Synonyms: MDA-9; MDA9; Melanoma differentiation-associated protein 9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; Scaffold protein Pbp1; SDCB1_HUMAN; Sdcbp; SDCBP; ST1; SYCL; Syndecan binding protein; syntenin; Syndecan binding protein 1; Syndecan-binding protein 1; Syntenin 1; Syntenin-1; TACIP18.

Host:  

Mouse

Application:  

WB

Reactivity:  

Human

Cat. No.: HY-P81310
Synonyms: SDCBP; MDA9; SYCL; Syntenin-1; Melanoma differentiation-associated protein 9; MDA-9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; TACIP18; Scaffold protein Pbp1; Syndecan-binding protein 1

Host:  

Mouse

Application:  

WB

Reactivity:  

Human

Cat. No.: HY-P71014A
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Syntenin-1; Melanoma differentiation-associated protein 9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; Scaffold protein Pbp1; Syndecan-binding protein 1; SDCBP; MDA9; SYCL;
Species:  
Source:  
Cat. No.: HY-P71014
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Syntenin-1; Melanoma differentiation-associated protein 9; Pro-TGF-alpha cytoplasmic domain-interacting protein 18; Scaffold protein Pbp1; Syndecan-binding protein 1; SDCBP; MDA9; SYCL;
Species:  
Source:  
Cat. No.: HY-B0633P
CAS No.: 9067-32-7
Synonyms: Sodium hyaluronate (MW 0.9M-1.0MDA)
Research Areas:  

Others

Hyaluronic acid sodium (MW 0.9M-1.0Mda) (Sodium hyaluronate (MW 0.9M-1.0Mda)) is a biopolymer composed of repeating units of disaccharides with a molecular weight of 0.9 M-1.0 Mda. Hyaluronic acid sodium (MW 0.9M-1.0Mda) can be used as a drug carrier for drug delivery .
Cat. No.: HY-RS24553
Research Areas:  

Others

Sdcbp Rat Pre-designed siRNA Set A contains three designed siRNAs for Sdcbp gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

  • 1